Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in the First Prospective Multicenter Trial for Pediatric, Adolescent, and Young Adult Patients with High Risk Acute Leukemias and Myelodysplastic Syndrome Meeting Abstract

International Collaboration

cited authors

  • Symons, Heather J.; Cluster, Andrew; Caywood, Emi; Dalal, Jignesh D.; Egeler, R. Maarten; Huo, Jeffrey S.; Hudspeth, Michelle; Keating, Amy K.; Kelly, Susan; Krueger, Joerg; Lee, Dean; Lehmann, Leslie E.; Madden, Lisa; Oshrine, Benjamin R.; Schneider, Heather; Schultz, Kirk R.; Pulsipher, Michael A.; Fry, Terry J.

authors

Publication Date

  • March 1, 2019

webpage

published in

category

volume

  • 25

issue

  • 3